Loading provider…
Loading provider…
Gastroenterology Physician in Lexington, KY
NPI: 1215712443Primary Practice Location
Lexington Surgery Center Ltd
2115 Harrodsburg Road, Lexington, KY
Primary Employer
Kentucky Medical Services Foundation, Inc
kmsf.com
HQ Phone
Get MD, FEBGH Ruben's Phone Numberphone_androidMobile
Get MD, FEBGH Ruben's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardKY State Medical License
KY State Medical License
Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma.
Authors: Barat, Samarpita, Bozko, Przemyslaw, Chen, Xi, Scholta, Tim, Hanert, Franziska, Götze, Julian, Malek, Nisar P, Wilkens, Ludwig, Plentz, Ruben R
Journal: Mol Carcinog
Publication Date: 2016-01-12
Correction: Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis.
Authors: Wutka, Annika, Palagani, Vindhya, Barat, Samarpita, Chen, Xi, El Khatib, Mona, Götze, Julian, Belahmer, Hanane, Zender, Steffen, Bozko, Przemyslaw, Malek, Nisar P, Plentz, Ruben R
Journal: PLoS One
Publication Date: 2016-09-20
Right upper abdominal pain, vomiting, weight loss and icterus in a 20-year-old male refugee
Authors: Kaire, K, Starke, A, Junker, K, Henschel, M, Dahlmann, M, Plentz, R R
Journal: Internist (Berl)
Lead Sponsor: University of Erlangen-Nürnberg Medical School
Intervention / Treatment: DRUG: Induction chemotherapy with gemcitabine or FOLFIRINOX, RADIATION: Radiotherapy, 28 x 1.8 Gy, DRUG: Chemotherapy, gemcitabine, DRUG: Chemotherapy with gemcitabine or FOLFIRINOX according to induction chemotherapy
Lead Sponsor: Pharmacyclics LLC.
Intervention / Treatment: DRUG: Ibrutinib, DRUG: Gemcitabine, DRUG: Nab-paclitaxel